Core Insights - Veris Health Inc. has established a strategic partnership with The Ohio State University Comprehensive Cancer Center (OSUCCC – James) following a successful pilot program of the Veris Cancer Care Platform™ [1][4] - The partnership aims to enhance personalized cancer care through remote patient monitoring and the development of the Veris Cancer Care Platform [2][3] Group 1: Partnership Details - The agreement includes a long-term, multi-project collaboration to further develop and commercialize the Veris Cancer Care Platform and its implantable physiologic monitor [2][3] - Key components of the partnership involve expanding commercial utilization across cancer care service lines, full electronic health record (EHR) integration, and launching a large clinical registry and clinical trial [3][4] Group 2: Platform Features - The Veris Cancer Care Platform offers remote physiological data collection, symptom reporting, telehealth capabilities, and EHR integration, aiming to improve personalized cancer care [4][5] - Patients enrolled in the platform receive a VerisBox™ with connected health care devices that transmit data to a cloud-based clinician portal, along with a patient smartphone app for symptom reporting and health tracking [5] Group 3: Company Background - PAVmed Inc. is a diversified commercial-stage medical technology company operating in medical devices, diagnostics, and digital health sectors, with Veris Health as its majority-owned subsidiary [7] - Veris Health focuses on enhancing personalized cancer care through innovative technologies, including the development of an implantable physiological monitor [7]

Core Insights - Biotricity has expanded its intellectual property portfolio with 14 new patents, bringing the total to 15 issued patents and 14 pending, highlighting its commitment to enhancing patient care through advanced diagnostic solutions [1][4] - The new patents focus on a multi-sensor patch device platform that can function as both a patch and a watch, allowing for versatile integration in remote patient monitoring [2][3] - The innovations aim to streamline diagnostic processes, enabling simultaneous diagnostic studies, which can significantly reduce delays in diagnosis and expedite treatment for patients [3][4] Company Overview - Biotricity is a Technology-as-a-Service (TaaS) company that specializes in diagnostic and chronic disease management solutions for healthcare providers and consumers [1][5] - The company aims to reform the healthcare market by bridging gaps in remote monitoring and chronic care management, providing comprehensive solutions for both medical and consumer markets [5]

Core Insights - Biotricity has expanded its intellectual property portfolio with 14 new patents, bringing the total to 15 issued patents and 14 pending, highlighting its commitment to enhancing patient care and diagnostic processes [1][4] - The new patents focus on a multi-sensor patch device platform that can function as both a patch and a watch, allowing for versatile integration in remote patient monitoring [2][3] - The innovations aim to enable simultaneous diagnostic studies, improving efficiency in patient care by reducing the need for multiple appointments and long wait times [3] Company Overview - Biotricity is a Technology-as-a-Service (TaaS) company specializing in diagnostic and chronic disease management solutions for healthcare providers and consumers [1][5] - The company aims to reform the healthcare market by bridging gaps in remote monitoring and chronic care management, providing comprehensive solutions for both medical and consumer markets [5] - The CEO emphasizes the importance of delivering actionable data to healthcare providers to facilitate quicker interventions and improve patient outcomes while also driving revenue through insurance reimbursement [4]